Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sensors (Basel) ; 19(8)2019 Apr 18.
Article in English | MEDLINE | ID: mdl-31003457

ABSTRACT

While smart metering applications have initially focused on energy and gas utility markets, water consumption has recently become the subject of increasing attention. Unfortunately, despite the large number of solutions available on the market, the lack of an open and widely accepted communication standard means that vendors typically propose proprietary data collection solutions whose adoption causes non-trivial problems to water utility companies in term of costs, vendor lock-in, and lack of control on the data collection infrastructure. There is the need for open and interoperable smart water metering solutions, capable of collecting data from the wide range of water meters on the market. This paper reports our experience in the development and field testing of a highly interoperable smart water metering solution, which we designed in collaboration with several water utility companies and which we deployed in Gorino Ferrarese, Italy, in collaboration with CADF (Consorzio Acque Delta Ferrarese), the water utility serving the city. At the core of our solution is SWaMM (Smart Water Metering Middleware), an interoperable wireless IoT middleware based on the Edge computing paradigm, which proved extremely effective in interfacing with several types of smart water meters operating with different protocols.

2.
Int J Pharm ; 412(1-2): 47-51, 2011 Jun 30.
Article in English | MEDLINE | ID: mdl-21497186

ABSTRACT

The use of medical devices containing highly criticized phthalates including di(2-ethylhexyl) phthalate (DEHP) has been challenged by European directive 2007/47/CE, put into effect in March 2010. New plasticizers are now being used to soften PVC in medical devices: trioctyltrimellitate (TOTM), di-isononyl-cyclohexan-1,2-dicarboxilate (DINCH) and di(2-ethylhexyl) terephthalate (DEHT). To quantify DEHP in nine DEHP-free medical devices made of PVC softened by alternative plasticizers, high performance liquid chromatography analysis with ultraviolet detection at 220 nm wavelength was achieved. An NMR spectroscopy was performed to confirm DEHP presence. Only two medical devices out of the nine tested were truly without DEHP. One of them showed traces of DEHP exceeding the threshold contamination of 0.1% in plastic mass set by REACH regulations. TOTM plasticizer is still incriminated when polyvinyl-chloride (PVC) is contaminated with DEHP. Manufacturers must verify the purity of their raw material, not only on PVC, but also on other soft plastics entering into the composition of medical infusion devices. The clinical consequences of exposure to certain levels of DEHP have not been evaluated. A solution could be to use alternative PVC-free materials.


Subject(s)
Diethylhexyl Phthalate/analysis , Endocrine Disruptors/analysis , Infusions, Parenteral/instrumentation , Plasticizers/analysis , Polyvinyl Chloride/chemistry , Catheters/standards , Chromatography, High Pressure Liquid , Equipment and Supplies/standards , European Union , Guideline Adherence , Legislation, Medical , Limit of Detection , Magnetic Resonance Spectroscopy , Materials Testing , Polyvinyl Chloride/standards , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...